UXT-V1 protects cells against TNF-induced apoptosis through modulating complex II formation

Molecular Biology of the Cell

Volumn 22, Issue 8, 2011, Pages 1389-1397

  Huang, Yuefeng ^a   Chen, Liang ^a   Zhou, Yi ^a   Liu, Heng ^a   Yang, Jueqing ^a   Liu, Zhenggang ^b   Wang, Chen ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ASSOCIATED DEATH DOMAIN PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR UXT V2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL PROTECTION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENE SILENCING; HALF LIFE TIME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; CELL NUCLEUS; CYTOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HALF-LIFE; HUMANS; MICE; MICROSCOPY, CONFOCAL; NEOPLASM PROTEINS; NF-KAPPA B; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954595372     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-10-0827     Document Type: Article

References (33)

1. Aggarwal BB (2003). Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3, 745-756. (Pubitemid 41070815)
2. Aota K, Azuma M, Tamatani T, Yamashita T, Ashida Y, Sato M (2002). Stable inhibition of NF-kappa B in salivary gland cells does not enhance sen-sitivity to TNF-alpha-induced apoptosis due to upregulation of TRAF-1 expression. Exp Cell Res 276, 111-119. (Pubitemid 34948356)
3. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA (2008). cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30, 689-700. (Pubitemid 351818251)
4. Bradham CA, Plumpe J, Manns MP, Brenner DA, Trautwein C (1998). Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275, G387-G392.
5. Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M (2006). The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 124, 601-613. (Pubitemid 43199444)
6. Dignam JD, Lebovitz RM, Roeder RG (1983). Accurate transcription initia-tion by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11, 1475-1489.
7. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006). Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22, 245-257.
8. Guiet C, Silvestri E, De Smaele E, Franzoso G, Vito P (2002). c-FLIP ef-ficiently rescues TRAF-2-/- cells from TNF-induced apoptosis. Cell Death Differ 9, 138-144. (Pubitemid 34144773)
9. Haas TL et al. (2009). Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell 36, 831-844.
10. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J (2000). Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as ef-fector molecule. Nat Immunol 1, 489-495.
11. Hsu H, Shu HB, Pan MG, Goeddel DV (1996). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduc-tion pathways. Cell 84, 299-308. (Pubitemid 26042835)
12. Irmler M et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195. (Pubitemid 27297457)
13. Kataoka T (2005). The caspase-8 modulator c-FLIP. Crit Rev Immunol 25, 31-58. (Pubitemid 40733355)
14. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P (1998). The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297-303. (Pubitemid 28188890)
15. Kreuz S, Siegmund D, Scheurich P, Wajant H (2001). NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21, 3964-3973. (Pubitemid 32476458)
16. Liu ZG (2005). Molecular mechanism of TNF signaling and beyond. Cell Res 15, 24-27.
17. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J (2001). NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21, 5299-5305. (Pubitemid 32702435)
18. Micheau O, Tschopp J (2003). Induction of TNF receptor I-mediated apop-tosis via two sequential signaling complexes. Cell 114, 181-190. (Pubitemid 36936912)
19. Oshima S et al. (2009). ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457, 906-909.
20. Park YC, Burkitt V, Villa AR, Tong L, Wu H (1999). Structural basis for self-association and receptor recognition of human TRAF2. Nature 398, 533-538.
21. Schneider-Brachert W et al. (2004). Compartmentalization of TNF receptor 1 signaling: Internalized TNF receptosomes as death signaling vesicles. Immunity 21, 415-428. (Pubitemid 39208342)
22. Schroer A, Schneider S, Ropers H, Nothwang H (1999). Cloning and char-acterization of UXT, a novel gene in human Xp11, which is widely and abundantly expressed in tumor tissue. Genomics 56, 340-343. (Pubitemid 29159915)
23. Sun S, Tang Y, Lou X, Zhu L, Yang K, Zhang B, Shi H, Wang C (2007). UXT is a novel and essential cofactor in the NF-kappaB transcriptional enhan-ceosome. J Cell Biol 178, 231-244. (Pubitemid 47076460)
24. Taneja SS, Ha S, Swenson NK, Torra IP, Rome S, Walden PD, Huang HY, Shapiro E, Garabedian MJ, Logan SK (2004). ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J Biol Chem 279, 13944-13952. (Pubitemid 38468927)
25. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996). Suppres-sion of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
26. Wajant H, Pfizenmaier K, Scheurich P (2003). Tumor necrosis factor signal-ing. Cell Death Differ 10, 45-65.
27. Wang CY, Mayo MW, Baldwin AS Jr (1996). TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274, 784-787. (Pubitemid 26398259)
28. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr (1998). NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
29. Wang L, Du F, Wang X (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693-703. (Pubitemid 351636305)
30. Wertz IE, Dixit VM (2010). Regulation of death receptor signaling by the ubiquitin system. Cell Death Differ 17, 14-24.
31. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006). Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8, 398-406.
32. Ye H, Park YC, Kreishman M, Kieff E, Wu H (1999). The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 4, 321-330. (Pubitemid 29499785)
33. Zhao H, Wang Q, Zhang H, Liu Q, Du X, Richter M, Greene MI (2005). UXT is a novel centrosomal protein essential for cell viability. Mol Biol Cell 16, 5857-5865. (Pubitemid 41752232)